| Application no. and date | 18213926.1 (espacenet) (Federated) (European Patent Register), 20150520 | | Patent/reg. no. and date | DK/EP 3531133, 20230823 | | Publication date | 20190828 | | Priority no. and date | US 201462005560 P, 20140530 | | EP pub. no. and date |
EP 3531133 20190828 | | Effective date | | | Applicant/owner | Amgen Inc., One Amgen Center Drive
Thousand Oaks, California 91320-1799, US,
Amgen Research (Munich) GmbH, Staffelseestrasse 2
81477 München, DE | | Applicant ref. no. | 1672500 | | Inventor | KUFER, Peter, c/o Amgen Research (Munich) GmbH
Staffelseestr. 2
81477 Munich, DE,
ZUGMAIER, Gerhard, c/o Amgen Research (Munich) GmbH
Staffelseestr. 2
81477 Munich, DE,
Alekar, Shilpa, c/o Amgen Inc
One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | G01N 33/574 (2006.01) | | Title | RISIKOSTRATIFICERING AF PATIENTER MED B-PRECURSOR AKUT LYMFOBLASTISK LEUKÆMI | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
